Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004791-39Phase 2Terminated
Phase 2, randomised trial in hot flash and vasomotor symptoms comparing Gabapentin with Venlafaxine (Efexor) (2 arms). Primary endpoints: Primary: comparative effect on hot flashes and Primary: comparative side effects. Started Mar 2008; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004791-39.